Results 61 to 70 of about 6,946 (216)
Addiction Biology, Volume 31, Issue 2, February 2026.In a randomized, double‐blind, placebo‐controlled crossover study, we investigated whether finasteride‐induced reduction of dihydrotestosterone alters alcohol cue‐elicited brain activity and craving in males with heavy episodic drinking. Although dihydrotestosterone concentrations were not associated with neural cue reactivity, finasteride increased ...
Rafat Boroumand‐Jazi +15 more
wiley +1 more source
Zanco Journal of Medical SciencesBackground and objective: Symptomatic benign prostatic hyperplasia (BPH) results in several symptoms including the lower urinary tract symptoms. Consequently, BPH may affect the bladder and finally the kidneys.
Wishyar Jamal Al-Bazzaz
doaj +1 more source
Asian Journal of Urology, 2022 Objective: To evaluate the efficacy and safety of simultaneous administration of dutasteride, tadalafil and solifenacin in the treatment of benign prostatic hyperplasia (BPH) with overactive bladder symptoms and lower urinary tract obstruction in ...
Kirill Kosilov +4 more
doaj +1 more source
Therapeutic Considerations Related to Finasteride Administration in Male Androgenic Alopecia and Benign Prostatic Hyperplasia [PDF]
, 2017 Finasteride has been used extensively until now as a relative efficient therapeutic option for male androgenic alopecia and benign prostatic hyperplasia.
Baconi, Daniela L +10 more
core +1 more source
Multi-therapies in androgenetic alopecia: review and clinical experiences. [PDF]
, 2016 Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of
Anzalone, Alessia +6 more
core +1 more source
Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson’s disease—STARTUP [PDF]
, 2020 Introduction Parkinson’s disease is the second most common chronic neurodegenerative condition with bladder dysfunction affecting up to 71%. Symptoms affect quality of life and include urgency, frequency, hesitancy, nocturia and incontinence.
Booth, Jo +10 more
core +3 more sources
BJU International, Volume 137, Issue 2, Page 332-338, February 2026.Objectives To assess the impact of 5α‐reductase inhibitors (5‐ARIs) on multiparametric magnetic resonance imaging (mpMRI) features of Prostate Imaging‐Reporting and Data System (PI‐RADS) lesions and their influence on the detection of clinically significant prostate cancer (csPCa), with a focus on differences between prostate zones.
Arighno Das +12 more
wiley +1 more source
The role of dutasteride in reducing complications of transurethral resection of prostate [PDF]
Al Ameen Journal of Medical SciencesPurpose: To evaluate the superiority of dutasteride over a placebo in patients having their prostate removed during transurethral resection for benign prostate hyperplasia. Material and Methods: The study included a total of 30 patients, with 15 patients
Shyamal Shah, P. Periasamy
doaj
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. [PDF]
, 2018 OBJECTIVES: To develop and validate a genetic tool to predict age of onset of aggressive prostate cancer (PCa) and to guide decisions of who to screen and at what age.
core +2 more sources
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 2, Page 210-223, February 2026.Optimal treatment for frontal fibrosing alopecia (FFA) remains contentious. An international expert panel agreed that highly/ultra‐potent topical steroids were the preferred first‐line topical therapy. Preferred systemic therapies were 5‐alpha reductase inhibitors, followed by hydroxychloroquine.
Nekma Meah +64 more
wiley +1 more source